Ameriprise’s Nutrien NTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $112M | Buy |
1,474,957
+101,664
| +7% | +$7.25M | 0.03% | 516 |
|
|
2025
Q4 | $84.8M | Buy |
1,373,293
+532,380
| +63% | +$31.3M | 0.02% | 624 |
|
|
2025
Q3 | $49.4M | Buy |
840,913
+9,088
| +1% | +$530K | 0.01% | 883 |
|
|
2025
Q2 | $48.5M | Sell |
831,825
-724,358
| -47% | -$40.9M | 0.01% | 882 |
|
|
2025
Q1 | $77.3M | Sell |
1,556,183
-354,637
| -19% | -$18.1M | 0.02% | 643 |
|
|
2024
Q4 | $85.6M | Buy |
1,910,820
+1,472
| +0.1% | +$69.9K | 0.02% | 606 |
|
|
2024
Q3 | $92M | Buy |
1,909,348
+45,684
| +2% | +$2.2M | 0.02% | 590 |
|
|
2024
Q2 | $95.1M | Buy |
1,863,664
+599,881
| +47% | +$32.8M | 0.03% | 537 |
|
|
2024
Q1 | $69.2M | Buy |
1,263,783
+72,458
| +6% | +$3.78M | 0.02% | 674 |
|
|
2023
Q4 | $67.7M | Buy |
1,191,325
+536,965
| +82% | +$30.3M | 0.02% | 654 |
|
|
2023
Q3 | $41.1M | Sell |
654,360
-38,421
| -6% | -$2.43M | 0.01% | 845 |
|
|
2023
Q2 | $41.4M | Sell |
692,781
-207,612
| -23% | -$13.2M | 0.01% | 853 |
|
|
2023
Q1 | $67.3M | Sell |
900,393
-448,744
| -33% | -$34.6M | 0.02% | 633 |
|
|
2022
Q4 | $99M | Buy |
1,349,137
+4,922
| +0.4% | +$389K | 0.03% | 478 |
|
|
2022
Q3 | $112M | Sell |
1,344,215
-551,836
| -29% | -$47.5M | 0.04% | 418 |
|
|
2022
Q2 | $151M | Sell |
1,896,051
-244,291
| -11% | -$23.7M | 0.05% | 358 |
|
|
2022
Q1 | $222M | Sell |
2,140,342
-1,014,959
| -32% | -$84.1M | 0.07% | 314 |
|
|
2021
Q4 | $237M | Buy |
3,155,301
+578,651
| +22% | +$40.5M | 0.07% | 310 |
|
|
2021
Q3 | $167M | Sell |
2,576,650
-1,479,905
| -36% | -$90.5M | 0.05% | 372 |
|
|
2021
Q2 | $246M | Buy |
4,056,555
+2,044,301
| +102% | +$121M | 0.08% | 279 |
|
|
2021
Q1 | $108M | Sell |
2,012,254
-3,651,342
| -64% | -$199M | 0.04% | 473 |
|
|
2020
Q4 | $273M | Sell |
5,663,596
-241,966
| -4% | -$10.7M | 0.1% | 224 |
|
|
2020
Q3 | $232M | Buy |
5,905,562
+1,660,704
| +39% | +$60.5M | 0.09% | 228 |
|
|
2020
Q2 | $136M | Buy |
4,244,858
+1,381,910
| +48% | +$48.1M | 0.06% | 320 |
|
|
2020
Q1 | $97.1M | Buy |
2,862,948
+57,564
| +2% | +$2.3M | 0.05% | 340 |
|
|
2019
Q4 | $134M | Buy |
2,805,384
+1,071
| +0% | +$51.8K | 0.06% | 325 |
|
|
2019
Q3 | $140M | Sell |
2,804,313
-38,124
| -1% | -$1.95M | 0.06% | 301 |
|
|
2019
Q2 | $152M | Sell |
2,842,437
-44,824
| -2% | -$2.34M | 0.07% | 292 |
|
|
2019
Q1 | $152M | Sell |
2,887,261
-163,934
| -5% | -$8.54M | 0.07% | 286 |
|
|
2018
Q4 | $143M | Sell |
3,051,195
-51,841
| -2% | -$2.7M | 0.07% | 281 |
|
|
2018
Q3 | $180M | Sell |
3,103,036
-171,101
| -5% | -$9.47M | 0.06% | 303 |
|
|
2018
Q2 | $178M | Buy |
3,274,137
+908,399
| +38% | +$45.1M | 0.08% | 259 |
|
|
2018
Q1 | $112M | Buy |
+2,365,738
| New | +$118M | 0.05% | 352 |
|
Other funds holding NTR
VCM
Ameriprise's NTR Position: Q1 2026 in Review
Ameriprise increased its Nutrien (NTR) stake by 7.4% in Q1 2026, buying an estimated $7.25M and bringing the position to 1,474,957 shares worth $112M. The position accounts for 0.03% of the portfolio, ranked #516.
Ameriprise first reported a position in NTR in Q1 2018 and has held it in 33 quarters since. The position peaked at $273M in Q4 2020. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.
- Ameriprise held 1,474,957 shares of Nutrien worth $112M as of Q1 2026.
- Ameriprise bought 101,664 Nutrien shares in Q1 2026, an estimated $7.25M.
- Nutrien made up 0.03% of Ameriprise's portfolio in Q1 2026, its #516 holding.
- Ameriprise first reported a position in Nutrien in Q1 2018 and has held it in 33 quarters since.
- Ameriprise's Nutrien position peaked at $273M in Q4 2020.
- 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.